Moreover, similar to the aforementioned proneural markers, CYP3A5 is highly expressed in GSCs that also exhibit mesenchymal markers such as BMI1 and CD44, supported by both single-cell RNA sequencing data and co-IF analysis of GBM samples (Fig. S4B, C). This evidence concerns the gene BMI1 and glioblastoma.